These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28050892)

  • 21. Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
    Choi G; Kwon OJ; Oh Y; Yun CO; Choy JH
    Sci Rep; 2014 Mar; 4():4430. PubMed ID: 24651154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer drug-inorganic nanohybrid and its cellular interaction.
    Kim JY; Choi SJ; Oh JM; Park T; Choy JH
    J Nanosci Nanotechnol; 2007 Nov; 7(11):3700-5. PubMed ID: 18047040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.
    Lee DH; Thoennissen NH; Goff C; Iwanski GB; Forscher C; Doan NB; Said JW; Koeffler HP
    Cancer Lett; 2011 Jul; 306(2):161-170. PubMed ID: 21440986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
    Amaral AC; Bocca AL; Ribeiro AM; Nunes J; Peixoto DL; Simioni AR; Primo FL; Lacava ZG; Bentes R; Titze-de-Almeida R; Tedesco AC; Morais PC; Felipe MS
    J Antimicrob Chemother; 2009 Mar; 63(3):526-33. PubMed ID: 19151037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
    Hegyi M; Arany A; Semsei AF; Csordas K; Eipel O; Gezsi A; Kutszegi N; Csoka M; Muller J; Erdelyi DJ; Antal P; Szalai C; Kovacs GT
    Oncotarget; 2017 Feb; 8(6):9388-9398. PubMed ID: 27566582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.
    Chen B; Yang JZ; Wang LF; Zhang YJ; Lin XJ
    BMC Cancer; 2015 Oct; 15():752. PubMed ID: 26486165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient drug delivery using SiO2-layered double hydroxide nanocomposites.
    Li L; Gu Z; Gu W; Liu J; Xu ZP
    J Colloid Interface Sci; 2016 May; 470():47-55. PubMed ID: 26930539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer.
    Chen Y; Zhang W; Gu J; Ren Q; Fan Z; Zhong W; Fang X; Sha X
    Int J Pharm; 2013 Aug; 452(1-2):421-33. PubMed ID: 23688623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
    Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
    J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate levels and outcome in osteosarcoma.
    Zelcer S; Kellick M; Wexler LH; Shi W; Sankaran M; Lo S; Healey J; Huvos AG; Meyers PA; Gorlick R
    Pediatr Blood Cancer; 2005 Jun; 44(7):638-42. PubMed ID: 15704189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
    Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y
    Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functionalized cell membrane biomimetic nanoformulation based on layered double hydroxide for combined tumor chemotherapy and sonodynamic therapy.
    Li G; Guo Y; Ni C; Wang Z; Zhan M; Sun H; Choi G; Choy JH; Shi X; Shen M
    J Mater Chem B; 2024 Jul; 12(30):7429-7439. PubMed ID: 38967310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
    Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
    Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
    Wang B; Yu XC; Xu SF; Xu M
    J Nanobiotechnology; 2015 Mar; 13():22. PubMed ID: 25880868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
    Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
    Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs.
    Bacci G; Ferrari S; Picci P; Zolezzi C; Gherlinzoni F; Iantorno D; Cazzola A
    J Chemother; 1996 Dec; 8(6):472-8. PubMed ID: 8981189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.